NCT04305236 Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04298983 Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer Status TERMINATED Phase PHASE2
NCT04294147 A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist Status COMPLETED Phase PHASE4
NCT04293393 Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04285671 Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04285229 A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE3
NCT04280081 A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04276428 A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT04276207 A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps Status COMPLETED Phase PHASE1
NCT04271202 Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action Status COMPLETED Phase PHASE4
NCT04259346 A Study of Two Formulations of Ixekizumab in Healthy Participants Status COMPLETED Phase PHASE1
NCT04258826 A Study to Evaluate LY3154207 on the Brain of Healthy Participants Status COMPLETED Phase PHASE1
NCT04255433 A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT04250350 Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04250337 Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. Status COMPLETED Phase PHASE3
NCT04238819 A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT04235959 A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1